These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 33303029)

  • 41. Matrix Hyaluronan Promotes Specific MicroRNA Upregulation Leading to Drug Resistance and Tumor Progression.
    Bourguignon LY
    Int J Mol Sci; 2016 Apr; 17(4):517. PubMed ID: 27070574
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MicroRNA-34a functions as an anti-metastatic microRNA and suppresses angiogenesis in bladder cancer by directly targeting CD44.
    Yu G; Yao W; Xiao W; Li H; Xu H; Lang B
    J Exp Clin Cancer Res; 2014 Dec; 33(1):779. PubMed ID: 25551284
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression profile of standard and variants forms of CD44 related to prostate cancer behavior.
    Moura CM; Pontes J; Reis ST; Viana NI; Morais DR; Dip N; Katz B; Srougi M; Leite KR
    Int J Biol Markers; 2015 Feb; 30(1):e49-55. PubMed ID: 24832177
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cancer-Associated MORC2-Mutant M276I Regulates an hnRNPM-Mediated CD44 Splicing Switch to Promote Invasion and Metastasis in Triple-Negative Breast Cancer.
    Zhang FL; Cao JL; Xie HY; Sun R; Yang LF; Shao ZM; Li DQ
    Cancer Res; 2018 Oct; 78(20):5780-5792. PubMed ID: 30093560
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CD44 correlates with clinicopathological characteristics and is upregulated by EGFR in breast cancer.
    Xu H; Wu K; Tian Y; Liu Q; Han N; Yuan X; Zhang L; Wu GS; Wu K
    Int J Oncol; 2016 Oct; 49(4):1343-50. PubMed ID: 27499099
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion.
    Cho SH; Park YS; Kim HJ; Kim CH; Lim SW; Huh JW; Lee JH; Kim HR
    Int J Oncol; 2012 Jul; 41(1):211-8. PubMed ID: 22552741
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of CD44 standard and isoforms in human breast cancer xenografts and shedding of soluble forms into serum of nude mice.
    Fichtner I; Dehmel A; Naundorf H; Finke LH
    Anticancer Res; 1997; 17(5A):3633-45. PubMed ID: 9413216
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CD44 in Ovarian Cancer Progression and Therapy Resistance-A Critical Role for STAT3.
    Martincuks A; Li PC; Zhao Q; Zhang C; Li YJ; Yu H; Rodriguez-Rodriguez L
    Front Oncol; 2020; 10():589601. PubMed ID: 33335857
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Doxorubicin induces drug resistance and expression of the novel CD44st via NF-κB in human breast cancer MCF-7 cells.
    Fang XJ; Jiang H; Zhu YQ; Zhang LY; Fan QH; Tian Y
    Oncol Rep; 2014 Jun; 31(6):2735-42. PubMed ID: 24715151
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells.
    Welsh CF; Zhu D; Bourguignon LY
    J Cell Physiol; 1995 Sep; 164(3):605-12. PubMed ID: 7544357
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of high CD44 expression in oral cancers using the novel monoclonal antibody, C
    Yamada S; Itai S; Nakamura T; Yanaka M; Kaneko MK; Kato Y
    Biochem Biophys Rep; 2018 Jul; 14():64-68. PubMed ID: 29872736
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New CD44 splice variants associated with human breast cancers.
    Iida N; Bourguignon LY
    J Cell Physiol; 1995 Jan; 162(1):127-33. PubMed ID: 7529235
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CD44v8-10 is a cancer-specific marker for gastric cancer stem cells.
    Lau WM; Teng E; Chong HS; Lopez KA; Tay AY; Salto-Tellez M; Shabbir A; So JB; Chan SL
    Cancer Res; 2014 May; 74(9):2630-41. PubMed ID: 24618343
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Prognostic Value of CD44 Expression in Epithelial-Mesenchymal Transition: Preliminary Data from Patients with Gastric and Esophageal Cancer.
    Schizas D; Moris D; Kanavidis P; Michalinos A; Sioulas A; Pavlakis K; Machairas A; Liakakos T
    In Vivo; 2016 11-12; 30(6):939-944. PubMed ID: 27815484
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CD44s Assembles Hyaluronan Coat on Filopodia and Extracellular Vesicles and Induces Tumorigenicity of MKN74 Gastric Carcinoma Cells.
    Härkönen K; Oikari S; Kyykallio H; Capra J; Hakkola S; Ketola K; Thanigai Arasu U; Daaboul G; Malloy A; Oliveira C; Jokelainen O; Sironen R; Hartikainen JM; Rilla K
    Cells; 2019 Mar; 8(3):. PubMed ID: 30909497
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CD44 is expressed in hepatocellular carcinomas showing vascular invasion.
    Mathew J; Hines JE; Obafunwa JO; Burr AW; Toole K; Burt AD
    J Pathol; 1996 May; 179(1):74-9. PubMed ID: 8691349
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enrichment of CD44 in basal-type breast cancer correlates with EMT, cancer stem cell gene profile, and prognosis.
    Xu H; Tian Y; Yuan X; Liu Y; Wu H; Liu Q; Wu GS; Wu K
    Onco Targets Ther; 2016; 9():431-44. PubMed ID: 26855592
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reduction of the putative CD44+CD24- breast cancer stem cell population by targeting the polyamine metabolic pathway with PG11047.
    Cirenajwis H; Smiljanic S; Honeth G; Hegardt C; Marton LJ; Oredsson SM
    Anticancer Drugs; 2010 Nov; 21(10):897-906. PubMed ID: 20838207
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparable roles of CD44v8-10 and CD44s in the development of bone metastases in a mouse model.
    Hiraga T; Nakamura H
    Oncol Lett; 2016 Oct; 12(4):2962-2969. PubMed ID: 27698884
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of CD44 isoforms in renal cell tumors. Positive correlation to tumor differentiation.
    Terpe HJ; Störkel S; Zimmer U; Anquez V; Fischer C; Pantel K; Günthert U
    Am J Pathol; 1996 Feb; 148(2):453-63. PubMed ID: 8579108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.